SCHEMBL2486112

SCHEMBL2486112

COc1ccc(-c2cc(=O)c3c(OC)cc(OCC(=O)NS(N)(=O)=O)cc3o2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.56
CYP1B1 Q16678 5/20 0.53
HDAC6 Q9UBN7 2/20 0.52
ABCB1 P08183 4/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
ABCG2 Q9UNQ0 3/20 0.51
TP53 P04637 1/20 0.51
MDM2 Q00987 1/20 0.51
CYP1A1 P04798 4/20 0.50
CYP1A2 P05177 4/20 0.50
OPRD1 P41143 1/20 0.50
POLH Q9Y253 1/20 0.48
KDM4E B2RXH2 3/20 0.48
MAPT P10636 3/20 0.48
CYP3A4 P08684 2/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2486820 0.91 PPARG (0.55) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2482027 0.87 PPARG (0.57) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2484742 0.87 PPARG (0.58) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2481857 0.86 MEN1 (0.59) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2481948 0.85 PPARG (0.57) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL14178905 0.85 ABCB1 (0.58) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2482206 0.85 PPARG (0.56) PPARGCYP1B1HDAC6ABCB1MEN1
Recoflavone SCHEMBL29406117 0.84 ABCB1 (0.59) PPARGCYP1B1HDAC6ABCB1MEN1
Recoflavone SCHEMBL2483541 0.84 ABCB1 (0.59) PPARGCYP1B1HDAC6ABCB1MEN1
SCHEMBL2483490 0.84 PPARG (0.55) PPARGCYP1B1HDAC6ABCB1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8203011-B2 3′,4′,5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same DONG-A PHARM. CO., LTD. (KR) 2012-06-19 US claimed
EP-2170857-B1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG A PHARM CO LTD (KR) 2011-10-19 EP claimed
US-20100130448-A1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULATN OF MUCUS SECRETION, METHOD FOR THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD (KR) 2010-05-27 US claimed
EP-2170857-A2 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Dong-A Pharm.Co., Ltd. (KR) 2010-04-07 EP claimed
WO-2008150085-A2 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD. (KR) 2008-12-11 WO claimed
US-8203011-B2 3′,4′,5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same DONG-A PHARM. CO., LTD. (KR) 2012-06-19 US disclosed
EP-2170857-B1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG A PHARM CO LTD (KR) 2011-10-19 EP disclosed
US-20100130448-A1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULATN OF MUCUS SECRETION, METHOD FOR THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD (KR) 2010-05-27 US disclosed
EP-2170857-A2 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Dong-A Pharm.Co., Ltd. (KR) 2010-04-07 EP disclosed
WO-2008150085-A2 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULANT OF MUCUS SECRETION, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD. (KR) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130448-A1 3',4',5-TRIMETHOXY FLAVONE DERIVATIVES AS STIMULATN OF MUCUS SECRETION, METHOD FOR THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME TLR5, PTN, TSLP PPARG 2853/4885CYP1B1 2614/4885HDAC6 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.